About Us
Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our proprietary AI platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, engineering, and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created.
About the Role
Reporting to the CSO, the Head of Platform Technology will define, grow, and manage a team responsible for evaluating, integrating, and advancing our NGS, genomics, molecular biology, and cellular technology capabilities. The team is responsible for applying these methods to generate high quality, proprietary, multi-omics data at scale for training and validation of AI capabilities for uncovering pathway biology and new biological mechanisms, novel target ID, and optimization of nucleic acid therapeutics. This is a highly innovative position that requires a deep understanding of NGS method development, genomic data generation, molecular biology, screening technologies, and a passion for developing cutting-edge genomic technologies. It also requires the ability to build production scale pipelines leveraging automation as appropriate to achieve scale, throughput, and reproducibility. You will work closely with the Machine Learning, Platform Biology, and Computational Biology teams to design experiments, analyze NGS data, and help interpret results for cross-functional teams.
Deep Genomics welcomes and encourages applications from people with disabilities. Accommodations are available on request for candidates taking part in all aspects of the selection process.
Deep Genomics thanks all applicants, however only those selected for an interview will be contacted.